BusinessVivos Demonstrates that IsoPet™ (RadioGel™) is effective in killing cancer in catsBy Nasdaq OMXMay 1, 2018, 1:02 PM UTC
BusinessVivos Adds Commercial Expertise to its Veterinary Medicine Advisory BoardBy Nasdaq OMXMar 20, 2018, 1:30 PM UTC
BusinessVivos Receives FDA Confirmation of RadioGel Device Classification for Animal Skin Cancer TherapyBy Nasdaq OMXJan 30, 2018, 2:02 PM UTC
BusinessVivos Completes Planned Dosing Schedule for Feline Sarcoma ProgramBy Nasdaq OMXJan 12, 2018, 4:53 PM UTC
